REPLICATION-COMPETENT ADENOVIRUS TYPE 4 SARS-COV-2 VACCINES AND THEIR USE
US Application 18/271,901
Filed on 2023-07-12
Filed on 2023-07-12
Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use
South Korea
10-2023-7027608
Filed on 2023-08-14
10-2023-7027608
Filed on 2023-08-14
Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use
China
202280010458.8
Filed on 2023-07-17
202280010458.8
Filed on 2023-07-17
Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use
Australia
2022208035
Filed on 2023-06-26
2022208035
Filed on 2023-06-26
Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use
Canada
3205052
Filed on 2023-06-12
3205052
Filed on 2023-06-12
Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use
Japan
2023-543164
Filed on 2023-07-14
2023-543164
Filed on 2023-07-14
Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use
India
202317048886
Filed on 2023-07-20
202317048886
Filed on 2023-07-20
Coronavirus Antibodies And Uses Thereof
US Application 18/026,544
Filed on 2023-03-15
Filed on 2023-03-15
Coronavirus Antibodies And Uses Thereof
Canada
3192706
Filed on 2023-03-14
3192706
Filed on 2023-03-14